Weight management, long-term (Saxenda) Mechanism: GLP-1 receptor agonist Dynamic interactions: Glucose lowering Kinetic interactions: Delayed gastric emptying, otherwise none in a bubble Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist available as a once-daily subcutaneous injectable
Your Semaglutide Injection Consultation Your consultation with Dr
Improved Patient Outcomes with Proactive Management When patients start a GLP-1 regimen, there is often an adjustment period during which side effects may occur
If you notice any cloudiness, discoloration, or floating particles, the solution may be contaminated or degraded and should be discarded
A diet with limited carbohydrates and saturated fat and enriched with high fiber and unsaturated fats, such as the Mediterranean diet, should be encouraged due to the cardiovascular benefits that are seen